Brainstorm Cell Therapeutics Inc. (BCLI)

NASDAQ: BCLI · IEX Real-Time Price · USD

0.487

-0.028 (-5.51%)

At close: May 31, 2024, 4:00 PM

0.540

+0.053 (10.95%)

After-hours: May 31, 2024, 7:05 PM EDT

BCLI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2007
Selling, General & Admin	10.69	10.87	9.3	9.36	5.8	Upgrade
Research & Development	10.75	13.96	15.24	22.33	17.2	Upgrade
Operating Expenses	21.44	24.82	24.54	31.68	23	Upgrade
Operating Income	-21.44	-24.82	-24.54	-31.68	-23	Upgrade
Interest Expense / Income	0.45	-0.55	0	0.13	0.25	Upgrade
Other Expense / Income	-4.69	-	-0.08	-	-	Upgrade
Pretax Income	-17.19	-24.28	-24.46	-31.81	-23.25	Upgrade
Net Income	-17.19	-24.28	-24.46	-31.81	-23.25	Upgrade
Shares Outstanding (Basic)	43	37	36	30	22	Upgrade
Shares Outstanding (Diluted)	43	37	36	30	22	Upgrade
Shares Change	17.99%	0.90%	21.22%	36.25%	9.54%	Upgrade
EPS (Basic)	-0.40	-0.66	-0.68	-1.07	-1.06	Upgrade
EPS (Diluted)	-0.40	-0.66	-0.68	-1.07	-1.06	Upgrade
Free Cash Flow	-20.48	-19.35	-26.6	-35.57	-11.72	Upgrade
Free Cash Flow Per Share	-0.47	-0.53	-0.73	-1.19	-0.54	Upgrade
EBITDA	-16.48	-24.54	-24.2	-31.47	-22.84	Upgrade
Depreciation & Amortization	0.27	0.29	0.26	0.22	0.16	Upgrade
EBIT	-16.75	-24.82	-24.46	-31.68	-23	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).